drugset / Trial / NCT07474792
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double-blinded, placebo-controlled, dose-range finding study to evaluate the efficacy and safety of ORKA-002 in adult participants with moderate-to-severe plaque psoriasis.
Timeline
- Start
- 2026-03-19
- Primary completion
- 2027-10
- Completion
- 2029-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORKA-002 | Unknown | — | Subcutaneous |